• History And Milestones
                                                                                      • In 1992, Poly was established in Hainan province.

                                                                                      • In 1995, Poly’s first product, Nimodipine capsule, gained Market Authorization in China.

                                                                                      • After 2010, Poly was subsequently inspected by authorities of WHO, EU EMA, US FDA. The first product Ganciclovir was exported to Germany and Netherlands.

                                                                                      • In 2015, the manufacturing facility in Hainan was rated as “Demonstration Factory of Intelligent Production in Pharmaceutical Industry” by Chinese government.

                                                                                      • In 2017, Poly completed Initial Public Offering and was listed on Shenzhen Stock Exchange (300630.SZ) with approximate US$1.5 billion of market value (July 2018).
                                                                                        A new facility in Hangzhou started its operation.

                                                                                      • In 2018, the third facility laid its foundation in Anqing for high-end API with designed capacity of 300 tons.

                                                                                      ©2017 Hainan Poly Co. Ltd All rights reserved     瓊ICP備11000362號-1